MedicarePartD.guide

A non-government resource built from CMS public data

Parkinson's disease drugs on every 2026 Delaware Part D plan

Pick a drug class, or type the drugs you want to check, and see which of the 10 stand-alone Part D plans in Delaware cover each one, on what tier, and with what restrictions.

A class overrides typed names. Separate names with commas; brand or generic both work.

  • Covered
  • Covered, needs prior authorization (PA) or step therapy (ST)
  • Not on the formulary
  • QL 60/30d = quantity limit, 60 units per 30 days
Parkinson's disease drugs by 2026 Delaware Part D plan
DrugHumana Basic Rx Plan$0.00/moS5884-103Humana Value Rx Plan$4.30/moS5884-184Wellcare Value Script$5.60/moS4802-140Wellcare Classic$5.70/moS4802-079HealthSpring Assurance Rx$32.60/moS5617-214AARP Medicare Rx Saver from UHC$37.80/moS5921-350HealthSpring Extra Rx$66.60/moS5617-355AARP Medicare Rx Preferred from UHC$94.50/moS5921-387SilverScript Choice$97.40/moS5601-010Humana Premier Rx Plan$108.60/moS5884-151
carbidopa-levodopageneric SinemetTier 2$1.00Tier 2$0.00Tier 2$3.00Tier 2$10.00Tier 2$2.00Tier 2$8.00Tier 2$5.00Tier 2$10.00Tier 2$7.00Tier 2$4.00
Rytarycarbidopa-levodopa extended-releaseNot coveredNot coveredNot coveredNot coveredTier 4ST30%Not coveredTier 4ST32%Not coveredNot coveredNot covered
pramipexolegeneric MirapexTier 2$1.00Tier 2$0.00Tier 1$0.00Tier 2$10.00Tier 2$2.00Tier 317%Tier 317%Tier 2$10.00Tier 2$7.00Tier 2$4.00
ropinirolegeneric RequipTier 2$1.00Tier 2$0.00Tier 2$3.00Tier 2$10.00Tier 2$2.00Tier 2$8.00Tier 2$5.00Tier 2$10.00Tier 2$7.00Tier 2$4.00
rasagilinegeneric AzilectTier 433%QL 30/30dTier 433%QL 30/30dTier 440%Tier 431%Tier 430%Tier 436%Tier 432%Tier 434%Tier 318%Tier 450%QL 30/30d
NourianzistradefyllineNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot covered
OngentysopicaponeNot coveredNot coveredNot coveredNot coveredTier 322%Not coveredTier 317%Not coveredNot coveredNot covered

Where a plan covers several strengths or forms of a drug, the cell shows the least restricted one. Costs are the 30-day preferred-pharmacy cost-sharing in the initial coverage phase, from the CMS 2026 formulary files. Click a plan for its full drug list.